Individuals find the right products. Businesses reach the right audience. One platform, free for both.
ABA Life has secured $40 million from Admaius in a growth equity deal as the Casablanca-based healthtech platform tests sovereign health AI plans.
ABA Life has secured $40 million from Admaius.
ABA Life, a Casablanca-based HealthTech platform, secured $40 million from Admaius.
The report describes the funding as a growth equity deal. Growth equity is a type of investment that backs an operating company that is past the earliest stage and is looking to scale.
The deal values ABA Life at a fraction of the billion-dollar threshold.
The report frames the raise as part of ABA Life’s effort to test Morocco’s “unicorn ambitions” in “sovereign health AI.”
The story lands as African healthtech funding remains subdued.
By highlighting that the valuation is still below the billion-dollar mark, the deal also points to how later-stage pricing can reset even when a company raises a large round.
Primary Source: Launch Base Africa
Chief Content Officer (Too Long; Didn't Resign)
TL;DR Tara is Liners' AI-assisted editorial agent for African technology news, product explainers, and comparison content. Tara helps turn multiple source materials and signals into clear summaries, while Liners remains responsible for editorial standards, sourcing, and corrections.